HYBIO PHARMACEUTICAL
Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of polypeptide drugs. On the basis of strict production management and quality control according to the GMP strictly, it breaks through the bottle-neck of the polypeptide drugs' large-scale production technology by means of introduction digestion, independent innovation, and any other patterns. Shenzhen Hybio Pharmaceutical has successively applied ... for 38 patents, with 5 patents for invention, 7 national new drug certificates, 5 new drug clinical trial permissions, and 45 drug registration letters. The drugs are mainly used to treat diseases such as digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, senile diseases, and more.
HYBIO PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.hybio.com.cn
Total Employee:
501+
Status:
Active
Contact:
+8675526588037
Total Funding:
97.78 M CNY
Technology used in webpage:
SPF SSL By Default Apache DigiCert SSL Java EE RapidSSL Alibaba Apache Tomcat Coyote HiChina DNS Tencent QQ Mail
Current Employees Featured
Stock Details
Investors List
SAIF Partners
SAIF Partners investment in Series B - Hybio Pharmaceutical
Shenzhen Capital Group
Shenzhen Capital Group investment in Series A - Hybio Pharmaceutical
SAIF Partners
SAIF Partners investment in Series A - Hybio Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-10-12 | GENERAL HEALTHY | Hybio Pharmaceutical investment in Angel Round - GENERAL HEALTHY | 84 M CNY |
| 2015-06-09 | Xietang Gao Guan | Hybio Pharmaceutical investment in Series A - Xietang Gao Guan | 60 M CNY |
Official Site Inspections
http://www.hybio.com.cn Semrush global rank: 6.07 M Semrush visits lastest month: 1.34 K
- Host name: 43.135.137.172
- IP address: 43.135.137.172
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Hybio Pharmaceutical"
Hybio
深圳翰宇药业股份有限公司成立于2003年4月，注册资本8.83亿元，是专业从事多肽药物研、产、销一体的国家高新技术企业。See details»
Hybio Pharmaceutical Co., Ltd.
Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the …See details»
Company Profile,About Us - Hybio
Hybio Pharmaceutical Co., LTD. (hereinafter referred to as: Hybio Pharmaceutical, stock code: 300199) is a National High-Tech Enterprise which specializes in the R&D, manufacture and …See details»
About us - Hybio
In the evolving world of peptide pharmaceuticals, Hybio Pharmaceutical actively engages with a profound commitment to research and development (R&D) and an unwavering dedication to …See details»
Hybio Pharmaceutical - Crunchbase Company Profile
Shenzhen Hybio Pharmaceutical Co., Ltd. (翰宇药业) is a high-tech enterprise which is engaged in research, development, production, and sales of …See details»
Diabetes Medication, Obesity Treatment, …
Hybio Pharmaceutical Co., Ltd. Founded in 1998, Hybio is a leading peptides company in China specializing in the development, manufacture and commercialization of …See details»
Hybio Group-Hybio Pharma
Hybio Biotechnology (Dali) Co., Ltd was established in June 14, 2019 as an industrial hemp deep processing. base with total investment over 74 million US dollars. Up to date, Hybio owns the …See details»
Hybio Pharma
Founded in 1998, Hybio is a leading peptides company in China specializing in the development, manufacture and commercialization of therapeutic peptides API and peptide …See details»
Hybio Pharmaceutical - Overview, News & Similar companies
Hybio Pharmaceutical contact info: Phone number: +86 75526588037 Website: www.hybio.com.cn What does Hybio Pharmaceutical do? Hybio has built the Manufacturing …See details»
Hybio Pharmaceutical Company Description - Stock Analysis
2 days ago Company profile for Hybio Pharmaceutical Co., Ltd. (SHE:300199) with a description, list of executives, contact details and other key facts.See details»
Hybio Pharmaceutical Co. Ltd Company Profile & Data: stocks, …
Jan 1, 2025 The company provides liraglutide, semaglutide and exenatide for diabetes; terlipressin, desmopressin and linaclotide for digestive tract and metabolic system; ganirelix, …See details»
Hybio Pharmaceutical Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hybio Pharmaceutical Co., Ltd. of Shenzhen, Guangdong. Get the latest business insights from Dun …See details»
Development history-Hybio Pharma
2011 2011 Hybio goes public. The shares are listed on the Shenzhen Stock Exchange (stock code: 300199) 2014 Acquired GS Changee Bio-Pharma Ltd. 2014 Eptifibatide injection ANDA …See details»
Development History，About Us - Hybio
Tel:0755-26588000 26588111 Fax:0755-26588022 Email:[email protected] Address：No.37, Keji C.2nd Hybio Medicine Park 粤ICP备13015240号 ...See details»
Hybio Pharmaceutical - Funding, Financials, Valuation & Investors
Hybio Pharmaceutical is registered under the ticker SZSE:300199 . Hybio Pharmaceutical is funded by 2 investors. SAIF Partners and Shenzhen Capital Group are the most recent …See details»
Hybio Pharmaceutica Co.,Ltd - Home
About us. Welcome To Our Site! Hybio Pharmaceutical Co., Ltd., a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptides, founded in 2003, is one of pioneers who …See details»
Hybio Pharmaceutical (Wuhan) Co., Ltd.
Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, we have grown up to be a leading peptide pharmaceutical …See details»
Hybio Pharmaceutical Co.. Ltd. - Drug pipelines, Patents ... - Patsnap
Primary study objective: To evaluate the similarity of the pharmacokinetic characteristics of semaglutide injection (test preparation, T; strength: 1.34 mg/mL (2 mg/1.5 mL)) produced by …See details»
Hybio Pharmaceutical 2025 Company Profile: Stock ... - PitchBook
Hybio Pharmaceutical General Information Description. Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage …See details»
GMP -Hybio Pharma
Over the years, Hybio has passed inspections from overseas and Chinese authorities and customers for an accumulated 150 times, covering its Shenzhen API site, Wuhan API site and …See details»